Malin-backed Immunocore files for $258m Nasdaq IPO
The UK biotech company says proceeds from the IPO will be used to advance its lead product
Malin-backed Poseida Therapeutics files for IPO on Nasdaq exchange
Poseida is one of four priority assets in which the life sciences company has stakes
Malin investee company Immunocore raises in excess of $130m
Irish life-sciences company invested $80m in Oxford-based company in July 2015
Woodford sells remaining Malin stake
Troubled asset manager thought to have sold 1.6m shares earlier this week
Malin chief sees demand for 23% Woodford stake
New CEO says company will have enough investor demand to absorb the holding if sold
Malin chief executive to step down after just one year in the role
Former Ardagh CEO Ian Curley to become executive chairman on an interim basis
Life sciences firm Malin looking to raise €31m in new share placing
Listed group, whose backers include Ireland Strategic Investment Fund, seeks new funds
Life sciences company Malin’s losses widen as revenue soars
Dublin-listed company reports €36.1 million pretax loss for first six months of 2016
Dublin-listed Malin secures €70m debt facility from EIB
Company to use facility to increase investments in European life sciences sector
Life sciences investment group Malin loses €9.6m in first half
Company reported its loss and revenue from investments at €2.5m in maiden set of results
Malin invests €73m in Immunocore, to raise €42m
Irish-based firm joins in Europe’s largest Series A life science financing
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices